HIGHFDA DEVICE

Mazor Robotics Recalls Robotic Guidance System Over Software Errors

Mazor Robotics recalled 549 Mazor X robotic guidance systems on December 10, 2025, due to software errors. These errors may cause incorrect surgical instrument positioning during spinal surgeries. Patients and healthcare providers must stop using the device immediately.

Official notice
Mazor RoboticsHealth & Personal CareMedical DevicesSoftware versions: 5.0.15.1.25.1.3/ UDI: 07290109180465

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
December 10, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
December 10, 2025
Hazard Level
HIGH
Brand
Mazor Robotics
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Mazor Robotics
Product type
Robotic Guidance System
Model numbers
Software versions: 5.0.1, 5.1.2, 5.1.3/ UDI: 07290109180465, 07290109184524, 07290109181158, 00763000635169, 07290109183213, 07290109184517 +6 more
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    December 10, 2025

  2. Reported by FDA DEVICE

    January 28, 2026

  3. RecallRadar source check

    February 4, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Software errors that can result in incorrect surgical instrument positioning during spinal surgery.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Mazor Robotics Ltd or your healthcare provider for instructions. Notification method: Letter

About This Product

The Mazor X robotic guidance system assists surgeons in performing spinal surgeries with enhanced precision. Healthcare providers use this device to improve outcomes and reduce risks during complex procedures.

Why This Is Dangerous

The software errors in the Mazor X guidance system can lead to incorrect positioning of surgical instruments, potentially compromising surgical accuracy and patient safety.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Patients and healthcare providers must take immediate action to avoid serious surgical risks. The recall may disrupt surgical schedules and affect patient treatment plans.

Practical Guidance

How to identify if yours is affected

  1. Check the software version of your Mazor X robotic guidance system.
  2. Refer to the list of affected software versions: 5.0.1, 5.1.2, 5.1.3.
  3. Contact your healthcare provider for assistance in checking if your system is affected.

Where to find product info

The software version can usually be found in the system's settings or user manual.

What timeline to expect

Expect a response regarding your recall inquiry within 4-6 weeks.

If the manufacturer is unresponsive

  • Document your communications with the company.
  • Contact the FDA to report unresponsiveness.
  • Consider consulting with a legal expert if necessary.

How to prevent similar issues

  • Ensure devices have the latest software updates before use.
  • Ask about device recalls during purchasing or service consultations.
  • Be aware of recent recalls in the healthcare field.

Documentation advice

Keep records of your purchase, any correspondence with the manufacturer, and notes on your system's software version.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The recall affects Mazor X robotic guidance systems with software versions 5.0.1, 5.1.2, and 5.1.3. These systems were distributed worldwide, including in the United States, Canada, and several European countries. The systems are classified as Class II medical devices.

Key Facts

  • Software errors can affect surgical procedures
  • Worldwide distribution including the US and several countries
  • Immediate stop-use action required
  • Contact manufacturer for further guidance

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Software versions: 5.0.1
5.1.2
5.1.3/ UDI: 07290109180465
07290109184524
07290109181158
+9 more
Affected States
ALL
Report Date
January 28, 2026
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

Taro Pharmaceuticals Withdraws Diclofenac Sodium Gel Over Viscosity Issues

Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.

BEEKEEPER'S NATURALS USA
Microbial Contamination
Read more
Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more